Furthermore, the activation of tumor-suppressive miRNA and the inhibition of oncogenic miRNA may have the potential to provide a fundamentally new approach for the development of therapeutics for many cancers, including ALK(+) ALCL. This evidence concerns the gene ALK and cancer.